Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-γ

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • F. H. Schmitz-Winnenthal - , Universität Heidelberg (Autor:in)
  • L. V. Galindo Escobedo - , Universität Heidelberg (Autor:in)
  • Philipp Beckhove - , Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • V. Schirrmacher - , Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • M. Bucur - , Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • Y. Ziouta - , Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • C. Volk - , Universität Heidelberg (Autor:in)
  • B. Schmied - , Universität Heidelberg (Autor:in)
  • M. Koch - , Universität Heidelberg (Autor:in)
  • D. Antolovic - , Universität Heidelberg (Autor:in)
  • J. Weitz - , Universität Heidelberg (Autor:in)
  • M. W. Büchler - , Universität Heidelberg (Autor:in)
  • K. Z'Graggen - , Klinik Beau-Site (Autor:in)

Abstract

Pancreatic carcinoma is a very aggressive disease and little is known about its immunobiology. We here describe the presence in pancreatic cancer patients of spontaneously induced functional CD4 and CD8 memory/effector T cells reactive to autologous tumor cells or to the pancreatic cancer associated antigen, MUC-1. Such specific cells were present in the bone marrow or peripheral blood of most of the 23 tested patients. Low dose stimulation of primary cultures of pancreatic cancer cells with 500 IU/ml IFN-γ for 72 h enhanced HLA-I expression and induced the de novo expression of HLA-II molecules. This led to a much better immune recognition by autologous HLA-I restricted and purified CD8 T cells and allowed tumor cell recognition by HLA-II restricted purified CD4 T-helper cells. Thus, interferon-γ appears to be a useful adjuvant cytokine to enhance the immunogenicity of a patients' tumor cells and their recognition by tumor reactive immune cells.

Details

OriginalspracheEnglisch
Seiten (von - bis)1419-1428
Seitenumfang10
FachzeitschriftInternational journal of oncology
Jahrgang28
Ausgabenummer6
PublikationsstatusVeröffentlicht - Juni 2006
Peer-Review-StatusJa
Extern publiziertJa

Externe IDs

PubMed 16685444

Schlagworte

Ziele für nachhaltige Entwicklung

ASJC Scopus Sachgebiete

Schlagwörter

  • Antigen presentation, Immunotherapy, Interferon-γ, Pancreatic cancer, Tumor-specific T cells